Profil
Kaushik J.
Dave served as President, CEO, CFO, Secretary & Director at Actinium Pharmaceuticals, Inc. from 2013 to 2017.
Prior to that, he was the Executive Vice President-Product Development at Antares Pharma, Inc. from 2008 to 2013 and Vice President-Product Development at Palatin Technologies, Inc. from 2001 to 2006.
He also worked as an Executive Director-Clinical & Regulatory Affairs at Insmed Ltd.
Dr. Dave received his undergraduate degree from the University of Bath, his doctorate from the University of Kansas, and his MBA from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Kaushik J. Dave
| Sociétés | Poste | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur Général | 12/05/2017 |
| ANTARES PHARMA, INC. | Directeur Technique/Scientifique/R&D | 17/06/2011 |
| PALATIN TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Insmed Ltd.
 Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Formation de Kaushik J. Dave
| University of Bath | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Health Technology |
